Brief: Allarity Therapeutics Reports Full Year 2025 Financial Results And Corporate Progress
31/03/2026 13:48
Allarity Therapeutics Inc ALLR.O: ALLARITY THERAPEUTICS REPORTS FULL YEAR 2025 FINANCIAL RESULTS AND CORPORATE PROGRESS Source text: ID:nGNX55ZlGY Further company coverage: ALLR.O
Recent news on Allarity Therapeutics
See all newsBrief: Allarity Therapeutics Announces Strategic Capital Allocation For Filing Of Spac Registration Statement
Allarity Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Allarity Therapeutics Q2 loss narrows as expenses fall
Allarity Therapeutics Inc expected to post a loss of 25 cents a share - Earnings Preview
Brief: Allarity Therapeutics Announces The Grant Of Essential U.S. Patent For Its Stenoparib Drp® Companion Diagnostic